EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients

Renata de Almeida Zieger, Mariana Rodrigues Botton, Marina Curra, Amanda de Farias Gabriel, Stefanie Thieme, Luisa Comerlato Jardim, Marco Antonio Trevizani Martins, Ursula da Silveira Matte, André Tesainer Brunetto, Lauro José Gregianin, Rafael Roesler, Stephen T Sonis und 2 weitere

Oral Diseases · 2025-06 · 31 (6) · 1765-1775

DOI: 10.1111/odi.15217 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Oral Diseases, online erschienen am 10.12.2024. Verfasst von Renata de Almeida Zieger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, School of Dentistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. Hauptthemen laut MEDLINE: Osteosarcoma, Stomatitis, Bone Neoplasms, Genetic Variation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: PRONON/Ministry of Health, Postgraduate Research Group of Porto Alegre Clinics Hospital, Brazilian National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The variability in patients' risk of oral mucositis (OM) has been, in part, attributed to differences in host genomics. The aim better define the role of genomics as an OM risk by investigating the association between genetic variants and the presence and severity of OM in pediatric patients with osteosarcoma (OS) undergoing chemotherapy (CT).

Methods

A longitudinal observational retrospective study was conducted. Severity of OM was assessed daily using World Health Organization (WHO) criteria. Blood samples were collected, and DNA was extracted. 54 coding regions were analyzed for 17 candidate genes using next‐generation sequencing.

Results

A total of 164 CT cycles were evaluated in 14 pediatric patients being treated for OS with HDMTX (66.9%) and doxorubicin + cisplatin (34.1%). OM was diagnosed in 129 cycles (78.7%). Whereas the presence of OM was associated with ABCA3 (rs13332514) in HDMTX cycles, OM severity was associated with ABCC2 (rs2273697) in multivariate analysis. In doxorubicin + cisplatin, genetic variants of ABC family genes ( ABCC2 and ABCC6 ) were associated with OM in multivariate analysis.

Conclusion

Oral mucositis risk and severity in a pediatric population being treated for OS with HDMTX, doxorubicin, and cisplatin were associated with genes in the ABC family ( ABCA3, ABCC2 , and ABCC6 genes).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaStomatitisBone NeoplasmsGenetic VariationHumansFemaleMaleChildRetrospective StudiesAdolescentCisplatinDoxorubicinMultidrug Resistance-Associated Protein 2Longitudinal StudiesSeverity of Illness IndexAntineoplastic Combined Chemotherapy ProtocolsATP-Binding Cassette, Sub-Family C ProteinsMethotrexateAntineoplastic Agents

Stichwörter der Autor:innen

chemotherapygenetic variantsoral mucositisosteosarcomapediatric patientspharmacogeneticspharmacogenomic

Substanzen

CisplatinDoxorubicinMultidrug Resistance-Associated Protein 2ATP-Binding Cassette, Sub-Family C ProteinsMethotrexateAntineoplastic AgentsABCC2 protein, human

Autor:innen und Institutionen

  • Department of Oral Pathology, School of Dentistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil.
  • Transplant Immunology and Personalized Medicine Unit, Hospital de Clínicas de Porto Alegre (HCPA/UFRGS), Porto Alegre, Brazil.
  • Department of Oral Pathology, University of Caxias Do Sul (UCS), Caxias do Sul, Porto Alegre, Brazil.
  • Department of Oral Medicine, Hospital de Clínicas de Porto Alegre (HCPA/UFRGS), Porto Alegre, Brazil.
  • Medical Genetics Service, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil.
  • Childhood Cancer Institute, Porto Alegre, Brazil.

ORCID-Profile: Manoela Domingues Martins

Förderung

  • PRONON/Ministry of Health
  • Postgraduate Research Group of Porto Alegre Clinics Hospital
  • Brazilian National Council for Scientific and Technological Development
  • Children's Cancer Institute
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil

Zitieren

APA

Zieger, R. A., Botton, M. R., Curra, M., Gabriel, A. F., Thieme, S., Jardim, L. C., Martins, M. A. T., Matte, U. D. S., Brunetto, A. T., Gregianin, L. J., Roesler, R., Sonis, S. T., Siebert, M., & Martins, M. D. (2025). Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients. Oral Diseases, 31(6), 1765-1775. https://doi.org/10.1111/odi.15217

Vancouver

Zieger RA, Botton MR, Curra M, Gabriel AF, Thieme S, Jardim LC, et al. Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients. Oral Diseases. 2025;31(6):1765-1775. doi:10.1111/odi.15217

BibTeX
@article{Zieger2025,
  author = {Zieger, Renata de Almeida and Botton, Mariana Rodrigues and Curra, Marina and Gabriel, Amanda de Farias and Thieme, Stefanie and Jardim, Luisa Comerlato and Martins, Marco Antonio Trevizani and Matte, Ursula da Silveira and Brunetto, André Tesainer and Gregianin, Lauro José and Roesler, Rafael and Sonis, Stephen T and Siebert, Marina and Martins, Manoela Domingues},
  title = {Genetic Variants Influence the Severity of Oral Mucositis in Pediatric Osteosarcoma Patients},
  journal = {Oral Diseases},
  year = {2025},
  volume = {31},
  number = {6},
  pages = {1765--1775},
  doi = {10.1111/odi.15217}
}
Kostenlos starten →